CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 475 of 764 entries

View as:

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Phase: N/A Priority: Normal

NCT ID: NCT00427453 Org: User:

Start: 06/30/03 End: 03/31/05 Due: 03/31/06

Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir

Phase: N/A Priority: Normal

NCT ID: NCT00980109 Org: User:

Start: 09/30/09 End: 09/30/10 Due: 09/30/11

G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria

Phase: N/A Priority: Normal

NCT ID: NCT02876549 Org: User:

Start: 09/01/16 End: 11/30/18 Due: 11/30/19

Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03529669 Org: User:

Start: 04/18/18 End: 01/30/20 Due: 01/30/21

Severe and Cerebral Malaria Investigated Through Host Metabolomics

Phase: N/A Priority: Normal

NCT ID: NCT02451904 Org: User:

Start: 06/30/15 End: 09/30/17 Due: 09/30/18

Rural South and Southeast Asia Household Health Survey

Phase: N/A Priority: Normal

NCT ID: NCT05389540 Org: User:

Start: 10/03/22 End: 12/10/23 Due: 12/10/24

Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia

Phase: N/A Priority: Normal

NCT ID: NCT00936767 Org: User:

Start: 10/31/10 End: 10/31/10 Due: 10/31/11

A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)

Phase: N/A Priority: Normal

NCT ID: NCT02453308 Org: User:

Start: 08/31/15 End: 03/31/18 Due: 03/31/19

The OPTIMISE Intervention for Reducing Meat Consumption in UK Adult Meat-eaters

Phase: N/A Priority: Normal

NCT ID: NCT04961216 Org: User:

Start: 03/15/21 End: 05/26/21 Due: 05/26/22

Malezi Na Kilimo Bora - Skilful Parenting and Agribusiness Child Abuse Prevention Study

Phase: N/A Priority: Normal

NCT ID: NCT02633319 Org: User:

Start: 08/01/15 End: 03/01/17 Due: 03/01/18

Statin Therapy In Atrial Refractoriness and Reperfusion Injury

Phase: N/A Priority: Normal

NCT ID: NCT01780740 Org: User:

Start: 01/31/12 End: 08/31/14 Due: 08/31/15

Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in Pregnancy

Phase: N/A Priority: Normal

NCT ID: NCT01916954 Org: User:

Start: 07/31/13 End: - Due: -

Controlled Human Malaria Infection Transmission Model - Phase A

Phase: N/A Priority: Normal

NCT ID: NCT04280692 Org: User:

Start: 08/22/22 End: 08/31/26 Due: 08/31/27

MIcroglial Colony Stimulating Factor-1 Receptor (CSF1R) in Alzheimer's Disease

Phase: N/A Priority: Normal

NCT ID: NCT04121208 Org: User:

Start: 04/07/21 End: 02/18/22 Due: 02/18/23

Acute Exacerbations Treated With BenRAlizumab (The ABRA Study)

Phase: N/A Priority: Normal

NCT ID: NCT04098718 Org: User:

Start: 03/29/21 End: 11/19/24 Due: 11/19/25

Tofacitinib in Depression (TIDE)

Phase: N/A Priority: Normal

NCT ID: NCT04141904 Org: User:

Start: 02/10/20 End: 05/23/22 Due: 05/23/23

A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia

Phase: N/A Priority: Normal

NCT ID: NCT04041791 Org: User:

Start: 08/19/19 End: 04/05/24 Due: 04/05/25

Investigating the Immune Response to 4CMenB in Infants

Phase: N/A Priority: Normal

NCT ID: NCT02080559 Org: User:

Start: 07/21/14 End: 04/27/18 Due: 04/27/19

Adults Regulating Their Weight Everyday With Mobile Internet Support

Phase: N/A Priority: Normal

NCT ID: NCT05787652 Org: User:

Start: 03/24/23 End: 03/23/25 Due: 03/23/26

Frontosubthalamic Networks in Parkinson's Disease.

Phase: N/A Priority: Normal

NCT ID: NCT06485986 Org: User:

Start: 06/01/24 End: 08/31/26 Due: 08/31/27

SPK Study in Afghanistan

Phase: N/A Priority: Normal

NCT ID: NCT01707199 Org: User:

Start: 10/31/12 End: 01/31/14 Due: 01/31/15

A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria

Phase: N/A Priority: Normal

NCT ID: NCT02044198 Org: User:

Start: 03/31/14 End: 12/31/14 Due: 12/31/15

Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)

Phase: N/A Priority: Normal

NCT ID: NCT02361788 Org: User:

Start: 01/28/15 End: 05/18/19 Due: 05/18/20

A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5

Phase: N/A Priority: Normal

NCT ID: NCT02181088 Org: User:

Start: 08/31/14 End: 10/31/15 Due: 10/31/16

Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen

Phase: N/A Priority: Normal

NCT ID: NCT00408668 Org: User:

Start: 08/31/05 End: 02/28/06 Due: 02/28/07

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously	NCT00427453	University of Oxford	user2@example.com	None	2003-06-30	2005-03-31	2006-03-31	-	-	2025-07-14
Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir	NCT00980109	University of Oxford	user2@example.com	None	2009-09-30	2010-09-30	2011-09-30	-	-	2025-07-14
G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria	NCT02876549	University of Oxford	user2@example.com	None	2016-09-01	2018-11-30	2019-11-30	-	-	2025-07-14
Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer	NCT03529669	University of Oxford	user2@example.com	None	2018-04-18	2020-01-30	2021-01-30	-	-	2025-07-14
Severe and Cerebral Malaria Investigated Through Host Metabolomics	NCT02451904	University of Oxford	user2@example.com	None	2015-06-30	2017-09-30	2018-09-30	-	-	2025-07-14
Rural South and Southeast Asia Household Health Survey	NCT05389540	University of Oxford	user2@example.com	None	2022-10-03	2023-12-10	2024-12-10	-	-	2025-07-14
Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia	NCT00936767	University of Oxford	user2@example.com	None	2010-10-31	2010-10-31	2011-10-31	-	-	2025-07-14
A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)	NCT02453308	University of Oxford	user2@example.com	None	2015-08-31	2018-03-31	2019-03-31	-	-	2025-07-14
The OPTIMISE Intervention for Reducing Meat Consumption in UK Adult Meat-eaters	NCT04961216	University of Oxford	user2@example.com	None	2021-03-15	2021-05-26	2022-05-26	-	-	2025-07-14
Malezi Na Kilimo Bora - Skilful Parenting and Agribusiness Child Abuse Prevention Study	NCT02633319	University of Oxford	user2@example.com	None	2015-08-01	2017-03-01	2018-03-01	-	-	2025-07-14
Statin Therapy In Atrial Refractoriness and Reperfusion Injury	NCT01780740	University of Oxford	user2@example.com	None	2012-01-31	2014-08-31	2015-08-31	-	-	2025-07-14
Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in Pregnancy	NCT01916954	University of Oxford	user2@example.com	None	2013-07-31	-	-	-	-	2025-07-14
Controlled Human Malaria Infection Transmission Model - Phase A	NCT04280692	University of Oxford	user2@example.com	None	2022-08-22	2026-08-31	2027-08-31	-	-	2025-07-14
MIcroglial Colony Stimulating Factor-1 Receptor (CSF1R) in Alzheimer's Disease	NCT04121208	University of Oxford	user2@example.com	None	2021-04-07	2022-02-18	2023-02-18	-	-	2025-07-14
Acute Exacerbations Treated With BenRAlizumab (The ABRA Study)	NCT04098718	University of Oxford	user2@example.com	None	2021-03-29	2024-11-19	2025-11-19	-	-	2025-07-14
Tofacitinib in Depression (TIDE)	NCT04141904	University of Oxford	user2@example.com	None	2020-02-10	2022-05-23	2023-05-23	-	-	2025-07-14
A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia	NCT04041791	University of Oxford	user2@example.com	None	2019-08-19	2024-04-05	2025-04-05	-	-	2025-07-14
Investigating the Immune Response to 4CMenB in Infants	NCT02080559	University of Oxford	user2@example.com	None	2014-07-21	2018-04-27	2019-04-27	-	-	2025-07-14
Adults Regulating Their Weight Everyday With Mobile Internet Support	NCT05787652	University of Oxford	user2@example.com	None	2023-03-24	2025-03-23	2026-03-23	-	-	2025-07-14
Frontosubthalamic Networks in Parkinson's Disease.	NCT06485986	University of Oxford	user2@example.com	None	2024-06-01	2026-08-31	2027-08-31	-	-	2025-07-14
SPK Study in Afghanistan	NCT01707199	University of Oxford	user2@example.com	None	2012-10-31	2014-01-31	2015-01-31	-	-	2025-07-14
A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria	NCT02044198	University of Oxford	user2@example.com	None	2014-03-31	2014-12-31	2015-12-31	-	-	2025-07-14
Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)	NCT02361788	University of Oxford	user2@example.com	None	2015-01-28	2019-05-18	2020-05-18	-	-	2025-07-14
A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5	NCT02181088	University of Oxford	user2@example.com	None	2014-08-31	2015-10-31	2016-10-31	-	-	2025-07-14
Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen	NCT00408668	University of Oxford	user2@example.com	None	2005-08-31	2006-02-28	2007-02-28	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance